Mitchell Batty
YOU?
Author Swipe
View article: Prevalence of Murray Valley encephalitis virus antibodies in northern Victoria following the 2023 outbreak: a cross-sectional serological survey
Prevalence of Murray Valley encephalitis virus antibodies in northern Victoria following the 2023 outbreak: a cross-sectional serological survey Open
Following the first outbreak of Murray Valley encephalitis in Victoria, Australia, since 1974, a serological survey was conducted in 2023 and 2024 to estimate the seroprevalence of Murray Valley encephalitis virus (MVEV) antibodies among r…
View article: Differential COVID-19 case ascertainment by age and vaccination status in Victoria, Australia: a serosurveillance and record linkage study
Differential COVID-19 case ascertainment by age and vaccination status in Victoria, Australia: a serosurveillance and record linkage study Open
Objectives: To compare serological evidence of prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with linked coronavirus disease 2019 (COVID-19) case notification data in Victoria, Australia, and to determine in …
View article: Serosurvey for Japanese encephalitis virus antibodies following an outbreak in an immunologically naïve population, Victoria, 2022: a cross‐sectional study
Serosurvey for Japanese encephalitis virus antibodies following an outbreak in an immunologically naïve population, Victoria, 2022: a cross‐sectional study Open
Objectives To investigate the distribution and prevalence of Japanese encephalitis virus (JEV) antibody (as evidence of past infection) in northern Victoria following the 2022 Japanese encephalitis outbreak, seeking to identify groups of p…
View article: Laboratory evaluation of ELISA and indirect immunofluorescence assay in response to emergence of Japanese encephalitis virus genotype IV in Australia
Laboratory evaluation of ELISA and indirect immunofluorescence assay in response to emergence of Japanese encephalitis virus genotype IV in Australia Open
The unexpected recent emergence of Japanese encephalitis virus (JEV) genotype IV in multiple southern states of Australia necessitated an evaluation of JEV serological tests suitable for diagnosing acute infection and for seroprevalence st…
View article: Analytical Sensitivity of Lateral Flow Devices against SARS-CoV-2 Omicron Subvariants BA.4, BA.5, and BA.2.75
Analytical Sensitivity of Lateral Flow Devices against SARS-CoV-2 Omicron Subvariants BA.4, BA.5, and BA.2.75 Open
Rapid antigen testing has played a pivotal role in the COVID-19 pandemic, enabling quick identification of individuals with SARS-CoV-2 infection, and rapid institution of clinical and public health measures. In many settings, including Aus…
View article: Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study
Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study Open
This work was funded by the Victorian Department of Health.
View article: Assessment of the Analytical Sensitivity of 10 Lateral Flow Devices against the SARS-CoV-2 Omicron Variant
Assessment of the Analytical Sensitivity of 10 Lateral Flow Devices against the SARS-CoV-2 Omicron Variant Open
Timely and accurate diagnostic testing is a critical component of the public health response to coronavirus (CoV) disease 2019 (COVID-19). Antigen (Ag) tests are used widely in many countries to provide rapid, economical, and accessible po…
View article: Assessment of twenty-two SARS-CoV-2 rapid antigen tests against SARS-CoV-2: A laboratory evaluation study
Assessment of twenty-two SARS-CoV-2 rapid antigen tests against SARS-CoV-2: A laboratory evaluation study Open
Background Rapid antigen testing is widely used as a way of scaling up population-level testing. To better inform antigen test deployment in Australia, we evaluated 22 commercially available antigen tests against the currently circulating …